Home
Scholarly Works
Primary end point analysis from the ESSENCE trial:...
Conference

Primary end point analysis from the ESSENCE trial: Enoxaparin vs unfractionated heparin in unstable angina and non-Q wave infarction.

Authors

Cohen M; Demers C; Gurfinkel E; Fromell G; Langer A; Turpie AGG

Volume

94

Pagination

pp. 3240-3240

Publisher

AMER HEART ASSOC

Publication Date

October 15, 1996

Conference proceedings

CIRCULATION

Issue

8

ISSN

0009-7322

Contact the Experts team